查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1831711

分子診斷市場，規模，佔有率，趨勢，產業分析報告:各產品，檢驗場所，各技術，各用途，各地區，2025年～2034年的市場預測

Molecular Diagnostics Market Size, Share, Trend, Industry Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology, By Application, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 127 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，分子診斷市場規模將達到 380.1 億美元。本研究報告深入分析了當前的市場動態，並對未來的市場成長進行了展望。

分子診斷市場專注於利用分子生物學技術檢測患者樣本中的遺傳物質、蛋白質和其他特定生物標記物，從而實現疾病的精準診斷、預後和監測。推動此市場發展的因素包括：對精準、快速、微創診斷方法的需求不斷增長，以支持個人化醫療；傳染病、癌症和遺傳性疾病的日益流行，也加速了分子診斷技術在臨床應用中的普及。

數位PCR、新一代定序和微陣列等技術的持續進步正在提高檢測的靈敏度、特異性和周轉時間，從而增強臨床決策能力。

醫護人員和病患對疾病早期檢測的認識不斷提高，推動了其在預防保健中的廣泛應用。人工智慧和自動化技術在檢測平台中的整合正在簡化工作流程、減少錯誤並提高實驗室效率。即時分子檢測（POC​​）的普及使診斷更加便捷及時，尤其是在急診環境中。診斷公司加大研發投入，催生出具有更廣泛檢測項目的創新檢測方法與平台。行業趨勢包括向分散式檢測模式的轉變、標靶治療伴隨診斷的成長以及診斷開發商和製藥公司之間合作的加強。機會包括擴展檢測組合以應對新出現的病原體、透過與數位醫療的整合利用遠端診斷以及推進多重檢測以在單次檢測中檢測多種病理。隨著精準醫療不斷重塑醫療保健格局，對快速、準確且可擴展的診斷解決方案的需求日益增長，該市場有望實現持續成長。

分子診斷市場報告亮點

按產品劃分，試劑系統細分市場將佔主導地位，約佔收入佔有率的 66%，這主要得益於常規分子診斷工作流程中耗材的持續需求。

按檢測地點劃分，中心實驗室細分市場將在 2024 年佔 80% 的收入佔有率，這主要歸功於處理大量檢測所需的先進設備和專業知識。

北美分子診斷市場將佔最大的收入佔有率，達 41%，這得益於先進分子檢測技術的廣泛應用和完善的醫療保健基礎設施。

亞太市場預計將在 2025 年至 2034 年間實現顯著增長，這主要得益於醫療保健投資的增加、先進診斷平台的快速普及以及慢性病和傳染病負擔的日益加重。

全球主要公司包括：雅培、安捷倫科技公司、BD、生物梅里埃、Bio-Rad Laboratories, Inc.、丹納赫、羅氏、基立福、豪洛捷（Gen Probe）、Illumina, Inc.、凱傑、西門子醫療和希森美康公司。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 分子診斷市場洞察

  • 市場概述
  • 分子診斷市場動態
    • 促進因素和機會
      • 常見傳染病
      • 支持性監管和資金舉措
    • 限制因素和挑戰
      • 設備和試劑成本高昂限制了其應用
  • PESTEL 分析
  • 分子診斷市場力量評估趨勢
  • 價值鏈分析

第5章 分子診斷市場:各產品

  • 主要調查結果
  • 簡介
  • 設備
  • 試劑
  • 其他

第6章 分子診斷市場:檢驗場所

  • 主要調查結果
  • 簡介
  • 照護現場
  • 自我檢測或OTC
  • 中心實驗室

第7章 分子診斷市場:各技術

  • 主要調查結果
  • 簡介
  • 聚合酵素鏈鎖反應(PCR)
  • 恆溫核酸增幅技術(INAAT)
  • 晶片和微陣列
  • 質譜分析
  • 轉錄介導擴增(TMA)
  • 其他

第8章 分子診斷市場:各用途

  • 主要調查結果
  • 簡介
  • 腫瘤學
  • 藥理基因學
  • 感染疾病
  • 遺傳基因檢驗
  • 神經疾病
  • 心血管疾病
  • 微生物學
  • 其他

第9章 分子診斷市場:各地區

  • 主要調查結果
  • 簡介
    • 分子診斷市場評估:地區，2020-2034年
  • 北美
    • 北美:各產品，2020～2034年
    • 北美:各檢驗場所，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各技術，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品，2020～2034年
    • 歐洲:各檢驗場所，2020～2034年
    • 歐洲:各用途，2020～2034年
    • 歐洲:各技術，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:各檢驗場所，2020～2034年
    • 亞太地區:各用途，2020～2034年
    • 亞太地區:各技術，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:各檢驗場所，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 中東·非洲:各技術，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各產品，2020～2034年
    • 南美:各檢驗場所，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各技術，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Abbott
  • Agilent Technologies, Inc.
  • BD
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche, Ltd
  • Grifols
  • Hologic Inc.(Gen Probe)
  • Illumina, Inc.
  • QIAGEN
  • Siemens Healthineers AG
  • Sysmex Corporation
Product Code: PM6073

The molecular diagnostics market size is expected to reach USD 38.01 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology, By Application, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The molecular diagnostics market focuses on the use of molecular biology techniques to detect genetic material, proteins, or other specific biomarkers in a patient's sample, enabling precise diagnosis, prognosis, and monitoring of diseases. This market has grown significantly due to the increasing demand for accurate, rapid, and minimally invasive diagnostic methods that support personalized medicine. The rising prevalence of infectious diseases, cancer, and genetic disorders has accelerated the adoption of molecular diagnostics in clinical settings. Continuous advancements in technologies such as digital PCR, next-generation sequencing, and microarrays are improving test sensitivity, specificity, and turnaround times, enhancing clinical decision-making.

Growing awareness among healthcare providers and patients about early disease detection is driving wider usage in preventive care. The integration of AI and automation in testing platforms is streamlining workflows and reducing errors, improving efficiency in laboratories. Expansion of point-of-care molecular testing is making diagnostics more accessible and timely, particularly in urgent care situations. Increasing investments in research and development by diagnostic companies is leading to innovative assays and platforms with broader test menus. Industry trends include a shift toward decentralized testing models, growth in companion diagnostics for targeted therapies, and rising collaborations between diagnostic developers and pharmaceutical companies. Opportunities lie in expanding test portfolios to address emerging pathogens, leveraging digital health integration for remote diagnostics, and advancing multiplex testing to detect multiple conditions in a single run. The market is positioned for sustained growth as precision medicine continues to shape healthcare, demanding fast, accurate, and scalable diagnostic solutions.

Molecular Diagnostics Market Report Highlights

By product, the reagents systems segment dominated the market with ~66% of the revenue share due to continuous demand for consumables in routine molecular diagnostic workflows.

Based on test location, the central laboratories segment held ~80% of the revenue share in 2024 due to their capability to process high testing volumes with advanced instrumentation and specialized expertise.

The North America molecular diagnostics market accounted for the largest revenue share of ~41% due to strong adoption of advanced molecular testing technologies, and supported by a well-established healthcare infrastructure.

The Asia Pacific market is expected to grow significantly during 2025-2034 due to increasing healthcare investments, rapid adoption of advanced diagnostic platforms, and the rising burden of chronic and infectious diseases.

A few global key players include Abbott; Agilent Technologies, Inc.; BD; BIOMERIEUX; Bio-Rad Laboratories, Inc.; Danaher; F. Hoffmann-La Roche, Ltd.; Grifols; Hologic Inc. (Gen Probe); Illumina, Inc.; QIAGEN; Siemens Healthineers AG; and Sysmex Corporation.

Polaris Market Research has segmented the molecular diagnostics market report on the basis of product, test location, technology, application, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Instruments

Reagents

Others

By Test Location Outlook (Revenue, USD Billion, 2020-2034)

Point of Care

Self-test or OTC

Central Laboratories

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Polymerase Chain Reaction (PCR)

PCR, by Procedure

Nucleic Acid Extraction

Others

PCR, by Type

Multiplex PCR

Other PCR

PCR, by Product

Instruments

Reagents

Others

In Situ Hybridization (ISH)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Chips and Microarrays

Mass Spectrometry

Transcription Mediated Amplification (TMA)

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Pharmacogenomics

Infectious Disease

MRSA

Clostridium Difficile

Tuberculosis and Drug-Resistant TB

Meningitis

Gonorrhea

HIV

Hepatitis C

Hepatitis B

Others

Genetic Testing

Neurological Disease

Cardiovascular Disease

Microbiology

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Molecular Diagnostics Market Insights

  • 4.1. Molecular Diagnostics Market - Market Snapshot
  • 4.2. Molecular Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Infectious Diseases
      • 4.2.1.2. Supportive Regulatory and Funding Initiatives
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of instruments and reagents limits adoption
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Molecular Diagnostics Market Power Rating Trends
  • 4.6. Value Chain Analysis

5. Molecular Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Instruments
    • 5.3.1. Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 5.4. Reagents
    • 5.4.1. Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
  • 5.5. Others
    • 5.5.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Molecular Diagnostics Market, by Test Location

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • 6.3. Point of care
    • 6.3.1. Molecular Diagnostics Market, by Point of care, by Region, 2020-2034 (USD Billion)
  • 6.4. Self-test or OTC
    • 6.4.1. Molecular Diagnostics Market, by Self-test or OTC, by Region, 2020-2034 (USD Billion)
  • 6.5. Central laboratories
    • 6.5.1. Molecular Diagnostics Market, by Central laboratories, by Region, 2020-2034 (USD Billion)

7. Molecular Diagnostics Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Polymerase chain reaction (PCR)
    • 7.3.1. Molecular Diagnostics Market, by Polymerase chain reaction (PCR), by Region, 2020-2034 (USD Billion)
    • 7.3.2. PCR, by Procedure
      • 7.3.2.1. Molecular Diagnostics Market, by PCR, by Procedure, by Region, 2020-2034 (USD Billion)
      • 7.3.2.2. Nucleic Acid Extraction
      • 7.3.2.2.1. Molecular Diagnostics Market, by Nucleic Acid Extraction, by Region, 2020-2034 (USD Billion)
      • 7.3.2.3. Others
      • 7.3.2.3.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
    • 7.3.3. PCR, by Type
      • 7.3.3.1. Molecular Diagnostics Market, by PCR, by Type, by Region, 2020-2034 (USD Billion)
      • 7.3.3.2. Multiplex PCR
      • 7.3.3.2.1. Molecular Diagnostics Market, by Multiplex PCR, by Region, 2020-2034 (USD Billion)
      • 7.3.3.3. Other PCR
      • 7.3.3.3.1. Molecular Diagnostics Market, by Other PCR, by Region, 2020-2034 (USD Billion)
    • 7.3.4. PCR, by Product
      • 7.3.4.1. Molecular Diagnostics Market, by PCR, by Product, by Region, 2020-2034 (USD Billion)
      • 7.3.4.2. Instruments
      • 7.3.4.2.1. Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
      • 7.3.4.3. Reagents
      • 7.3.4.3.1. Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
      • 7.3.4.4. Others
      • 7.3.4.4.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
    • 7.3.5. In Situ Hybridization (ISH)
      • 7.3.5.1. Molecular Diagnostics Market, by In Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
  • 7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.4.1. Molecular Diagnostics Market, by Isothermal Nucleic Acid Amplification Technology (INAAT), by Region, 2020-2034 (USD Billion)
  • 7.5. Chips and Microarrays
    • 7.5.1. Molecular Diagnostics Market, by Chips and Microarrays, by Region, 2020-2034 (USD Billion)
  • 7.6. Mass Spectrometry
    • 7.6.1. Molecular Diagnostics Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
  • 7.7. Transcription Mediated Amplification (TMA)
    • 7.7.1. Molecular Diagnostics Market, by Transcription Mediated Amplification (TMA), by Region, 2020-2034 (USD Billion)
  • 7.8. Others
    • 7.8.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Molecular Diagnostics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Oncology
    • 8.3.1. Molecular Diagnostics Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 8.4. Pharmacogenomics
    • 8.4.1. Molecular Diagnostics Market, by Pharmacogenomics, by Region, 2020-2034 (USD Billion)
  • 8.5. Infectious disease
    • 8.5.1. Molecular Diagnostics Market, by Infectious disease, by Region, 2020-2034 (USD Billion)
    • 8.5.2. Oncology
      • 8.5.2.1. Molecular Diagnostics Market, by Oncology, by Region, 2020-2034 (USD Billion)
    • 8.5.3. MRSA
      • 8.5.3.1. Molecular Diagnostics Market, by MRSA, by Region, 2020-2034 (USD Billion)
    • 8.5.4. Clostridium difficile
      • 8.5.4.1. Molecular Diagnostics Market, by Clostridium difficile, by Region, 2020-2034 (USD Billion)
    • 8.5.5. Tuberculosis and drug-resistant TB
      • 8.5.5.1. Molecular Diagnostics Market, by Tuberculosis and drug-resistant TB, by Region, 2020-2034 (USD Billion)
    • 8.5.6. Meningitis
      • 8.5.6.1. Molecular Diagnostics Market, by Meningitis, by Region, 2020-2034 (USD Billion)
    • 8.5.7. Gonorrhea
      • 8.5.7.1. Molecular Diagnostics Market, by Gonorrhea, by Region, 2020-2034 (USD Billion)
    • 8.5.8. HIV
      • 8.5.8.1. Molecular Diagnostics Market, by HIV, by Region, 2020-2034 (USD Billion)
    • 8.5.9. Hepatitis C
      • 8.5.9.1. Molecular Diagnostics Market, by Hepatitis C, by Region, 2020-2034 (USD Billion)
    • 8.5.10. Hepatitis B
      • 8.5.10.1. Molecular Diagnostics Market, by Hepatitis B, by Region, 2020-2034 (USD Billion)
    • 8.5.11. Others
      • 8.5.11.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 8.6. Genetic testing
    • 8.6.1. Molecular Diagnostics Market, by Genetic testing, by Region, 2020-2034 (USD Billion)
  • 8.7. Neurological disease
    • 8.7.1. Molecular Diagnostics Market, by Neurological disease, by Region, 2020-2034 (USD Billion)
  • 8.8. Cardiovascular disease
    • 8.8.1. Molecular Diagnostics Market, by Cardiovascular disease, by Region, 2020-2034 (USD Billion)
  • 8.9. Microbiology
    • 8.9.1. Molecular Diagnostics Market, by Microbiology, by Region, 2020-2034 (USD Billion)
  • 8.10. Others
    • 8.10.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Molecular Diagnostics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Molecular Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Molecular Diagnostics Market - North America
    • 9.3.1. North America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.3.3. North America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.3.4. North America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.5. Molecular Diagnostics Market - US
      • 9.3.5.1. US: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.6. Molecular Diagnostics Market - Canada
      • 9.3.6.1. Canada: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.4. Molecular Diagnostics Market - Europe
    • 9.4.1. Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.5. Molecular Diagnostics Market - UK
      • 9.4.5.1. UK: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.6. Molecular Diagnostics Market - France
      • 9.4.6.1. France: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.7. Molecular Diagnostics Market - Germany
      • 9.4.7.1. Germany: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.8. Molecular Diagnostics Market - Italy
      • 9.4.8.1. Italy: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.9. Molecular Diagnostics Market - Spain
      • 9.4.9.1. Spain: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.10. Molecular Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.11. Molecular Diagnostics Market - Russia
      • 9.4.11.1. Russia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.12. Molecular Diagnostics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.5. Molecular Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.5. Molecular Diagnostics Market - China
      • 9.5.5.1. China: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.6. Molecular Diagnostics Market - India
      • 9.5.6.1. India: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.7. Molecular Diagnostics Market - Malaysia
      • 9.5.7.1. Malaysia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.8. Molecular Diagnostics Market - Japan
      • 9.5.8.1. Japan: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.9. Molecular Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.10. Molecular Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.11. Molecular Diagnostics Market - Australia
      • 9.5.11.1. Australia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.12. Molecular Diagnostics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.6. Molecular Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.5. Molecular Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.6. Molecular Diagnostics Market - UAE
      • 9.6.6.1. UAE: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.7. Molecular Diagnostics Market - Israel
      • 9.6.7.1. Israel: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.8. Molecular Diagnostics Market - South Africa
      • 9.6.8.1. South Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.9. Molecular Diagnostics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 9.7. Molecular Diagnostics Market - Latin America
    • 9.7.1. Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.5. Molecular Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.6. Molecular Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.7. Molecular Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.8. Molecular Diagnostics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. BD
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BIOMERIEUX
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Bio-Rad Laboratories, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Danaher
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. F. Hoffmann-La Roche, Ltd
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Grifols
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Hologic Inc. (Gen Probe)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Illumina, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. QIAGEN
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Siemens Healthineers AG
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Sysmex Corporation
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development

List of Tables:

  • Table 1 Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 2 Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 3 Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 4 Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 5 North America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 6 North America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 7 North America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 8 North America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 US: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 10 US: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 11 US: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 12 US: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 13 Canada: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 14 Canada: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 15 Canada: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 17 Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 18 Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 19 Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 21 UK: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 22 UK: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 23 UK: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 24 UK: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 25 France: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 26 France: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 27 France: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 28 France: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 29 Germany: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 30 Germany: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 31 Germany: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 32 Germany: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 33 Italy: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 34 Italy: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 35 Italy: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Italy: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 37 Spain: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 38 Spain: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 39 Spain: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Spain: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 45 Russia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 46 Russia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 47 Russia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 48 Russia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 57 China: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 58 China: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 59 China: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 60 China: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 61 India: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 62 India: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 63 India: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 64 India: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 Japan: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 70 Japan: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 71 Japan: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Japan: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 77 South Korea: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 78 South Korea: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 79 South Korea: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 80 South Korea: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 81 Australia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 82 Australia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 83 Australia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Australia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 97 UAE: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 98 UAE: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 99 UAE: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 100 UAE: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 101 Israel: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 102 Israel: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 103 Israel: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 104 Israel: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 105 South Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 106 South Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 107 South Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 108 South Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 113 Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 114 Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 115 Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 117 Mexico: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 118 Mexico: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 119 Mexico: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Mexico: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 121 Brazil: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 122 Brazil: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 123 Brazil: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 124 Brazil: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 125 Argentina: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 126 Argentina: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 127 Argentina: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 128 Argentina: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Molecular Diagnostics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Molecular Diagnostics Market, By Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Test Location
  • Figure 9. Molecular Diagnostics Market, By Test Location, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Molecular Diagnostics Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Technology
  • Figure 13. Molecular Diagnostics Market, by Technology, 2024 & 2034 (USD Billion)